
Cosmo Pharmaceuticals NV
SIX:COPN

Intrinsic Value
The intrinsic value of one
COPN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 46.3 CHF,
Cosmo Pharmaceuticals NV
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Cosmo Pharmaceuticals NV
Fundamental Analysis


Revenue & Expenses Breakdown
Cosmo Pharmaceuticals NV
Balance Sheet Decomposition
Cosmo Pharmaceuticals NV
Current Assets | 202.3m |
Cash & Short-Term Investments | 143m |
Receivables | 45.8m |
Other Current Assets | 13.5m |
Non-Current Assets | 444.5m |
Long-Term Investments | 31.8m |
PP&E | 29.1m |
Intangibles | 355.9m |
Other Non-Current Assets | 27.7m |
Free Cash Flow Analysis
Cosmo Pharmaceuticals NV
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Cosmo Pharmaceuticals NV
Revenue
|
266.8m
EUR
|
Cost of Revenue
|
-45.4m
EUR
|
Gross Profit
|
221.4m
EUR
|
Operating Expenses
|
-72.5m
EUR
|
Operating Income
|
148.9m
EUR
|
Other Expenses
|
-15.6m
EUR
|
Net Income
|
133.2m
EUR
|
COPN Profitability Score
Profitability Due Diligence
Cosmo Pharmaceuticals NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Cosmo Pharmaceuticals NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.
COPN Solvency Score
Solvency Due Diligence
Cosmo Pharmaceuticals NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Cosmo Pharmaceuticals NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COPN Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for
COPN
is 99.71 CHF
with a low forecast of 79.79 CHF and a high forecast of 139.65 CHF.
Dividends
Current shareholder yield for COPN is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
COPN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 46.3 CHF,
Cosmo Pharmaceuticals NV
is
hidden
.